» Articles » PMID: 26581368

Natural History of Asymptomatic Papillary Thyroid Microcarcinoma: Time-Dependent Changes in Calcification and Vascularity During Active Surveillance

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 2015 Nov 20
PMID 26581368
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prospective trials of non-surgical observation have shown progression rates of only 5-10% in patients with asymptomatic papillary microcarcinoma (PMC). This study investigated time-dependent changes in calcification patterns and tumor vascularity on ultrasonography (US) to clarify the natural course of PMC.

Methods: We examined calcification patterns and tumor vascularity for 480 lesions in 384 patients. Calcification patterns were classified as: (A) none; (B) micro; (C) macro; or (D) rim. Tumor vascularity was classified as rich or poor via color Doppler US.

Results: After a mean of 6.8 years of observation, 29 lesions (6.0%) had increased in size. Mean age for initial calcification pattern was 52.1 years for A (n = 135), 54.2 years for B (n = 235), 56.3 years for C (n = 96), and 60.1 years for D (n = 14), and the incidence rates of tumor enlargement were 9.6, 5.5, 3.2, and 0%, respectively. The cumulative rate of upgrade in calcification pattern was 51.8% at 10 years. Lesions with initially rich vascularity (n = 70) had significantly higher rate of tumor enlargement than those with poor vascularity (n = 410); however, the majority of tumor (61.4%) with initially rich vascularity had decreased their blood supply during the follow-up. Multivariate analysis showed that strong calcification (C or D) and poor vascularity at last examination correlated significantly with non-progressive disease.

Conclusions: PMCs in older patients showed significantly stronger calcification patterns and poorer vascularity. Both consolidation of calcification and loss of vascularity occurred in a time-dependent manner during observation and were significant indicators for non-progressive disease.

Citing Articles

Regressed Papillary Thyroid Carcinoma with Anaplastic Transformation into Lymph Node Metastasis: Case Report with Review of the Literature.

Kovacevic B, Rancic B, Jovic S, Cerovic S, Skuletic V, Karajovic J Diagnostics (Basel). 2025; 15(5).

PMID: 40075771 PMC: 11898554. DOI: 10.3390/diagnostics15050523.


Analysis of features of papillary thyroid carcinoma on color Doppler ultrasound images: implications for lymph node metastasis.

Cao L, Cao Y, Wang X, Lu X, Zhao F, Sun L BMC Med Imaging. 2025; 25(1):75.

PMID: 40050763 PMC: 11883915. DOI: 10.1186/s12880-025-01615-2.


Standardized Ultrasound Evaluation for Active Surveillance of Low-Risk Thyroid Microcarcinoma in Adults: 2024 Korean Society of Thyroid Radiology Consensus Statement.

Lee J, Lee M, Lim H, Lee C, Sung J, Yoon J J Korean Soc Radiol. 2024; 85(6):1060-1082.

PMID: 39660311 PMC: 11625847. DOI: 10.3348/jksr.2024.0132.


Long-term outcomes of active surveillance for low-risk papillary thyroid carcinoma: Progression patterns and tumor calcification.

Sugitani I, Nagaoka R, Saitou M, Sen M, Kazusaka H, Matsui M World J Surg. 2024; 49(1):159-169.

PMID: 39592419 PMC: 11711112. DOI: 10.1002/wjs.12417.


Standardized Ultrasound Evaluation for Active Surveillance of Low-Risk Thyroid Microcarcinoma in Adults: 2024 Korean Society of Thyroid Radiology Consensus Statement.

Lee J, Lee M, Lim H, Lee C, Sung J, Yoon J Korean J Radiol. 2024; 25(11):942-958.

PMID: 39473087 PMC: 11524690. DOI: 10.3348/kjr.2024.0871.


References
1.
FUKUNAGA F, Yatani R . Geographic pathology of occult thyroid carcinomas. Cancer. 1975; 36(3):1095-9. DOI: 10.1002/1097-0142(197509)36:3<1095::aid-cncr2820360338>3.0.co;2-9. View

2.
Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A . Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2013; 24(1):27-34. PMC: 3887422. DOI: 10.1089/thy.2013.0367. View

3.
Davies L, Welch H . Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295(18):2164-7. DOI: 10.1001/jama.295.18.2164. View

4.
Cooper D, Doherty G, Haugen B, Hauger B, Kloos R, Lee S . Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19(11):1167-214. DOI: 10.1089/thy.2009.0110. View

5.
Kim B, Choi Y, Kwon H, Lee J, Heo J, Han Y . Relationship between patterns of calcification in thyroid nodules and histopathologic findings. Endocr J. 2012; 60(2):155-60. DOI: 10.1507/endocrj.ej12-0294. View